CD20-positive Diffuse Large B-Cell Lymphoma
2 clinical trials · Condition
◉ Watch CD20-positive Diffuse Large B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of TRS005 in Patients With CD20-positive R/R DLBCL. (NCT06886139) | Zhejiang Teruisi Pharmaceutical Inc. | 2025-09-01 |
| GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma (NCT02495454) | Fondazione Italiana Linfomi - ETS | 2015-08-25 |
Track CD20-positive Diffuse Large B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.